key: cord-0754148-vrxrarrl authors: Macarov, Michal; Schneider, Nina; Eilat, Avital; Yahalom, Claudia title: Genetic counseling practice for inherited eye diseases in an Israeli medical center during the COVID‐19 pandemic date: 2021-07-19 journal: J Genet Couns DOI: 10.1002/jgc4.1479 sha: 32b17d5a4eff5a1770887461a64993b8bcf2d3cf doc_id: 754148 cord_uid: vrxrarrl Inherited eye diseases (IED) are among the most common causes for childhood and young adulthood blindness in developed countries. Genetic counseling and testing have become an essential part of caregiving for families affected by one of these severe ocular pathologies. The objective of our study is to describe our experience during the 2020 (COVID‐19) pandemic, following a practice protocol of safe genetic counseling for inherited ophthalmic diseases. We conducted a review of the genetic counseling practices from January until December 2020 in a multidisciplinary clinic for patients with visual impairment, in a tertiary hospital. The new protocol covered patient screening, required personal protective equipment, and the implementation of telemedicine. One hundred and eighty‐three counseling sessions were done in this period of time; 33/183 were telemedicine counseling. The results of this study indicate that the practice of genetic counseling in regard to inherited eye diseases in the era of COVID‐19 is effective and safe. Despite the high risk of infectivity that threatened healthcare professionals, safety measures adopted to reduce the risk of infection allowed us to prevent the cancelation of routine counseling, while keeping patient care our priority. The use of telemedicine was a very useful tool for providing counseling during lockdown periods in 2020. Genetic counseling and testing have become an integral part of patient care in ophthalmology, playing an important role in helping patients to understand the transmission of inherited eye disease (IED), means of prevention, and possible genetic therapy in some cases (Stone et al., 2012) . Genetic testing has significantly advanced in the field of ophthalmology over the past decades, moving from mainly 'research' to an important clinical service for patients. The number of known disease-causing genes has increased significantly, and their screening in parallel and at a low cost is readily available. A molecular diagnosis is essential for patient eligibility for new therapies such as voretigene neparvovec for RPE65-associated retinal degeneration, and other new clinical trials investigating the use of approaches such as gene replacement, small molecule drugs for nonsense mutation suppression, and antisense oligonucleotides for splice modulation (Russell et al., 2017; Havens & Hastings, 2016; Rodrigues et al., 2019; Richardson et al., 2020) . A clear molecular diagnosis assists in providing the affected family with data on the disease's course and expected prognosis, provides comfort to the patient and/or their family, and also aids their family planning decisions (Méjécase et al., 2020) . Due to the COVID-19 pandemic, most clinics and hospitals have decreased patient care of nonessential health services, including Inherited eye diseases (IED) are among the most common causes for childhood and young adulthood blindness in developed countries. Genetic counseling and testing have become an essential part of caregiving for families affected by one of these severe ocular pathologies. The objective of our study is to describe our experience during the 2020 (COVID-19) pandemic, following a practice protocol of safe genetic counseling for inherited ophthalmic diseases. We conducted a review of the genetic counseling practices from January until December 2020 in a multidisciplinary clinic for patients with visual impairment, in a tertiary hospital. The new protocol covered patient screening, required personal protective equipment, and the implementation of telemedicine. One hundred and eighty-three counseling sessions were done in this period of time; 33/183 were telemedicine counseling. The results of this study indicate that the practice of genetic counseling in regard to inherited eye diseases in the era of COVID-19 is effective and safe. Despite the high risk of infectivity that threatened healthcare professionals, safety measures adopted to reduce the risk of infection allowed us to prevent the cancelation of routine counseling, while keeping patient care our priority. The use of telemedicine was a very useful tool for providing counseling during lockdown periods in 2020. COVID-19, genetic counseling, inherited eye disease, telemedicine genetic counseling, to slow the spread of the virus (Lai et al., 2020) . However, delaying genetic counseling can be problematic, for example, in situations where genetic testing would affect decisions during a pregnancy or candidacy for gene replacement therapy (Stone, 2007) . Genetic counseling practice can involve several visits to undergo anamnesis and physical evaluation, receive genetic test results, and attend follow-up appointments. Telemedicine can be effectively utilized in this area as an alternative to standard clinic visits, even after this pandemic has ended (Hilgart et al., 2012; Saleem et al., 2020; Shannon et al., 2020) . During the first lockdown in our country in March-April 2020, the ministry of health in Israel instructed to close all elective medical practice in the country. In our center, most visits and genetic counseling sessions were canceled. In May, elective medical services were re-established; in our clinic, patients were contacted and offered to choose between telemedicine (to try to reduce direct patient-healthcare professional encounter) or in-person counseling. Hereby we present the genetic counseling experience during the 2020 COVID-19 pandemic in our multidisciplinary clinic, treating children and families with an IED leading to visual impairment or blindness. The ophthalmic genetic counseling and testing practice is an integral part of this center, which together with our social worker provides emotional support for families in distress when learning the cause of an IED and updating patients and their relatives regarding different available related resources. Retrospective review of genetic counseling practice for ocular diseases was conducted, during the 2020 (COVID-19) pandemic, from January until December 2020, in a multidisciplinary clinic for patients with low vision in a tertiary hospital in Israel. Our team includes two senior pediatric ophthalmologists, a social worker, two licensed genetic counselors specialized in ophthalmic diseases, four low vision optometrists, and a secretary. Our multidisciplinary center takes care of our visually impaired patients and families in many life aspects, such as medical diagnosis and treatment, social needs, governmental support, and assessing need as well as provision of special glasses and visual aids. Patients with suspected inher- During the studied period, 183 genetic counseling sessions were done, and 33/183 were done using telemedicine (Table 1) (Table 1) . Telemedicine has been used in genetic counseling in previous years and has become a useful tool during the COVID-19 pandemic. Genetic counseling in ophthalmology has become of critical importance in preventing future incidences of blindness in a family. Furthermore, genetic therapy is available for some inherited eye diseases and can prevent visual deterioration in children and young adults. Using a safe protocol and telemedicine allowed continuance of this essential healthcare service during the COVID-19 pandemic. The use of telephonic counseling was very high and all patients were happy to take this option and avoid reaching the hospital where a possible expose to COVID-19 could occur. Some patients were asked to come to an in-person counseling session due to special situations in which the rest of the multidisciplinary team was needed as part of the diagnosis/emotional support and others. Regarding presumed COVID-19-free individuals who opted to come to clinics, a protocol was followed to define risk levels of each patient regarding COVID-19. Assessment of body temperature and a basic questionnaire to identify patients with possible exposure to COVID-19 were administered. The questionnaire included questions about symptoms (fever, dry cough, sore throat, diarrhea, headache, loss of taste/smell) and proximity to a confirmed COVID-19 case as well as travel abroad history. Face-to-face visits for patients with suspicious symptoms were swapped with telemedicine, based largely on telephone calls. Personal protective equipment included the use of surgical masks and hand hygiene measures both for patients and healthcare personnel. Academic and administrative meetings were conducted over video chatting. Clinical rotations for students of genetic counseling were reduced during national lockdown based on the level of infections that the country was presently experiencing. Staff members were routinely tested every 14 days to rule out COVID-19 and quarantined in case of contact with a patient confirmed positive for COVID-19 infection. Two separate negative PCR tests were required to be performed prior to returning to the clinic. No workers in this multidisciplinary center were infected by COVID-19 during 2020, thanks in part to this protocol used for safe practice. The practice of genetic counseling in regard to IED in the era of COVID-19 can be effective and safe. Despite the high risk of infectivity that threatens health workers, safety measures adopted to reduce the risk of infection among healthcare providers allowed us to prevent the cancelation of ophthalmic genetic counseling, while prioritizing patient care. The use of telemedicine was a very useful tool for providing counseling. Before COVID-19, we did not have any experience with telemedicine. When telephone counseling was offered, most of our patients were open to telephone call encounters. Visually impaired patients did not report to have any challenges with telemedicine. In special cases, where learning the cause and implications of an IED could possibly cause emotional stress, patients were encouraged to come in person for genetic counseling so that emotional support could be provided to the family during this difficult moment, if needed. Other situations in which we requested patients to physically come in are when a new low vision patient with an uncertain diagnosis or in need of support in their daily activities needed the multidisciplinary assistance we provide at our center. Since June 2020, we went back to almost all normal activities in our center, despite the new partial lockdowns that did not include medical services. The service of in-person counseling was offered relatively more frequently as a full multidisciplinary team, compared to telephonic counseling. The use of telephonic counseling was high when offered, but since June 2020 we only offered it for special cases. In the first months since 2021, we find ourselves more organized in terms of offering telephonic counseling in certain cases where the full multidisciplinary team is not needed, such as in cases where patients just need confirmation of genetic testing results which was done in a research setting, or a known IED in other family members. In the near future, we expect to improve our telemedicine services by using videoconference services on top of telephonic con- tions (da Luz, 2019; Newton, 2014) . In addition, the current work environment is highly advanced in technology, with video-equipped computers, high-resolution cell phone cameras, and fast broadband internet service (Lurie & Carr, 2018 The long-term impact of COVID-19 pandemic on public health is yet to be seen. Re-structuration of health care in general, and of the genetic counseling service in particular, is needed in order to continue to provide patients with the assistance needed. We may find that among our low-vision patients, widespread acceptance of telephone genetic counseling continues even though the pandemic declines. Claudia Yahalom was involved in conception, design, writing, in- The data reported here was collected as part of quality improvement measures and does not constitute research requiring IRB review. No human studies were carried out by the authors for this article. No nonhuman animal studies were carried out by the authors for this article. Data available within the article. Claudia Yahalom https://orcid.org/0000-0001-7747-3568 Telemedicine and the doctor/patient relationship Splice-switching antisense oligonucleotides as therapeutic drugs Telegenetics: A systematic review of telemedicine in genetics services Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: An experience from Hong Kong. Graefe's Archive for The role of telehealth in the medical response to disasters Practical guide to genetic screening for inherited eye diseases The promise of telemedicine Mechanism and evidence of nonsense suppression therapy for genetic eye disorders Pharmaceutical development of AAVbased gene therapy products for the eye Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: A randomised, controlled, open-label Virtual Ophthalmology: Telemedicine in a COVID-19 Era Transition to telephone genetic counseling services during the COVID-19 pandemic Genetic testing for inherited eye disease Recommendations for genetic testing of inherited eye diseases: Report of the American academy of ophthalmology task force on genetic testing Genetic counseling practice for inherited eye diseases in an Israeli medical center during the COVID-19 pandemic